Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in WVE — Wave Life Sciences, Inc.

CIK 861177 NEW YORK, NY

Position in WVE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$16,849
-$1,615,225 QoQ
Shares Held
2,900
-98.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#194
of 237 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WVE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. WVE ranks #156 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WVE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,849 2,900
2026-03-31 $1,632,074 225,114
2025-12-31 $2,804,745 164,985
2025-06-30 $1,917,895 295,061
2025-03-31 $1,481,886 183,402
2024-12-31 $2,043,993 165,238
2024-09-30 $1,186,687 144,718
2024-06-30 $853,532 171,049
2024-03-31 $463,076 75,053
2023-12-31 $287,981 57,026
2021-03-31 $126,812 22,605
2020-12-31 $273,488 34,751
2020-09-30 $219,787 25,888
2020-06-30 $242,468 23,292